Welcome to Tianjin Institute of Pharmaceutical Research
Tianjin Institute of Pharmaceutical Research, the parental organization of Tianjin Center for Drug safety Assessment and Research (TDAR), was originally founded in 1959. TDAR was accredited by China State FDA (SFDA) GLP in 2006. It has now become one of the key research bases for preclinical Assessment for novel medicine, based on the high level service in pharmacokinetics, pharmacodynamics and drug safety evaluation.
Copyright 2014, a2z, Inc. All rights reserved.